NTRA
NateraยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NTRA Profile
Natera, Inc.
A global leader in cell-free DNA testing
13011 McCallen Pass, Building A Suite 100, Austin, TX 78753
--
Natera, Inc., was incorporated in Delaware in January 2007. The company is a diagnostic company with proprietary molecular and bioinformatics technology that is being applied to transform disease management on a global scale. The company's cell-free DNA (CFDNA) technology combines novel molecular analysis methods that reliably measure many information regions across the genome from samples ranging from small to individual cells, as well as statistical algorithms that combine data provided by the wider scientific community to identify genetic variants covering a wide range of serious diseases with high precision and coverage. The company's goal is to make personalized genetic testing and diagnosis part of the standard of care that protects health and inform earlier and more targeted interventions to help achieve longer, healthier lives.
